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This study aims to understand seizure control outcomes and the risk of developing new wake seizures (WS) related to the 
different types of pure sleep epilepsies (SE), which is important in making rational management plans. A retrospective review 
of the Yonsei Epilepsy Clinic Registry identified 63 patients with pure SE not belonging to any specific epileptic syndromes. 
They were divided into the group of generalized tonic-clonic seizures during sleep (S-GTCS : n = 21) and the group of partial 
epilepsies during sleep (S-PE : n = 42) on the basis of seizure phenomenology, EEG. and neuroimaging data. These patients were 
followed for 2 years and their clinical variables were analysed for seizure control outcomes and development of new WS. Of 21 
patients with S-GTCS, I7 achieved a seizure-free outcome and only one patient developed a new WS, which was consistent with a 
partial-onset secondary GTCS in phenomenology. Of 42 patients with S-PE only I5 patients achieved a seizure-free outcome and 
I I patients developed WS during the 2-year follow-up period. Higher baseline seizure frequency and longer duration of epilepsy 
were associated with a higher incidence of new WS. The results suggest that the patients with S-GTCS carry a favorable clinical 
course, thus driving privileges or freedom of daily activities can be conferred without delay once their seizures are well controlled. 
However, the seizure control outcome was poor and the development of WS was frequent in patients with recurrent S-PE. 
Key words: sleep epilepsy (SE); wake seizure (WS); generalized tonic-clonic seizure during sleep (S-GTCS); partial epilepsy 
during sleep (S-PE). 
INTRODUCTION 
Sleep epilepsy (SE), i.e. recurrent seizures during 
sleep, implies important medico-legal or social signif- 
icance to the patient’s daily life. Investigations into the 
clinical course of SE are mandatory for their proper 
management. 
Previously, SE has been divided into the pure SE 
(seizure recurrences exclusively during sleep) and the 
predominant SE. Young et al’ disclosed different clini- 
cal characteristics in the two groups of SE. Pure SE was 
associated with a higher proportion of GTCS, lower fre- 
quency of seizure recurrences, lower incidence of iden- 
tifiable etiologies of seizure, and less abnormal neuro- 
logical examinations compared with predominant SE. 
Previous studies2v3 often included both types of SE 
and reported a relatively high incidence of SE (30% to 
45%), while the incidence of pure SE reported in more 
recent studies’q4q5 were around 5% to 7.5%. These sug- 
gest that pure SE is a different clinical group from pre- 
dominant SE. 
Previous efforts to identify the SE as a distinct clin- 
ical entity6*7 have been hampered by the many differ- 
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ent clinical features found in this group of patients. 
The seizure types seen in these patients were usu- 
ally either generalized tonic-clonic seizures (GTCS) 
or complex partial seizures (CPS) but simple partial 
seizures were also described’*4.7. In addition, SE can 
be found in patients with many different epileptic syn- 
dromes, i.e. benign rolandic epilepsy5, temporal lobe 
epilepsys, frontal lobe epilepsy’, or idiopathic general- 
ized epilepsies 5* lo. Insufficient description of epileptic 
attacks is also a problem with SE. Because of its oc- 
currence during sleep the patient is not aware of the 
occurrence of auras or the attacks, and may wake up in 
the morning with a bitten tongue, evidence of enure- 
sis, headache, or even without any specific complaints. 
Observers are often absent or they frequently fail to ob- 
serve the initial part of epileptic attacks which is essen- 
tial for correct diagnosis of seizure type. These factors 
often make the correct diagnosis of seizure type dif- 
ficult and the international classification of epilepsies 
and epileptic syndromes ” has included the nocturnal 
grand mals in the category 3.2, ‘epilepsies and syn- 
dromes undetermined whether focal or generalized’. 
Another problem with SE is the occasional occur- 
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rence of wake seizures (WS) in patients who initially 
presented with pure SE. Janz2 reported that 20% of 
nocturnal grand ma1 epilepsies become diffuse in cir- 
cadian rhythms on prolonged follow-up. Gibberd and 
Bateson found that 35 of 64 patients with SE had con- 
tinuing sleep attacks, 15 stopped having attacks, and 16 
started WS at the end of 3 years of follow-up. After 3 
years the incidence of WS decreased significantly but 
some patients still developed WS after many years of 
pure SE. On the other hand, D’Allesandro et al5 re- 
ported that only four of 34 patients with sleep GTCS 
developed WS during 2 years of follow-up and all four 
patients had their seizure onset less than 2 years before 
their initial visit. These results suggest hat SE includes 
many heterogeneous epileptic syndromes with variable 
degrees of interaction with the sleep-wake cycle. This 
study was conducted to discover the clinical course of 
pure SE in relation to seizure type. 
PATIENTS AND METHODS 
Patients 
We retrospectively reviewed the epilepsy clinic registry 
and the medical records of the patients newly attend- 
ing the Yonsei Epilepsy Clinic (YEC) during the pe- 
riod from 1 January 1990 to 3 1 August 1994. The YEC 
registry included a thorough history of past illnesses, 
family history of epilepsies, description of seizure phe- 
nomenology, timing of seizure attacks, seizure fre- 
quencies and previous history of antiepileptic drugs 
(AEDs) therapy. All patients underwent a 60minute 
recording of a 21-channel scalp EEG after overnight 
sleep deprivation with routinely employed 7’1, T2 and 
nasopharyngeal electrodes. At least one neuroimaging 
study, either CT scan or MRJ, was recommended to all 
patients. The timing of recurrent seizures related to the 
sleep-wake cycle was specified either on the seizure 
diary or medical charts on their regular visits, which 
was confirmed further, if necessary, by telephone con- 
versations. 
The patient inclusion criteria were (i) exclusive oc- 
currence of epileptic attacks during sleep before their 
initial evaluation, (ii) at least two or more unprovoked 
seizures, (iii) longer than 2 years of follow-up. We ex- 
cluded the patients if their seizures occurred at awak- 
ening or if they belonged to well-defined epileptic syn- 
dromes, i.e. benign rolandic epilepsy, juvenile myo- 
clonic epilepsy, juvenile absence epilepsy, etc. 
Classification of sleep epilepsies 
According to the guidelines of international classifica- 
tion of epileptic seizures t* , the descriptions of epileptic 
attacks are divided into grand ma1 seizures (GMS) and 
partial seizures with or without secondary generalized 
tonic-clonic seizures (PS). GMS included generalized 
convulsive seizures without any documented focal fea- 
tures (the descriptions were either complete or incom- 
plete) and PS included non-convulsive seizures, unilat- 
eral or asymmetric convulsive seizures, or GMS pre- 
ceded by either non-convulsive behavioral changes or 
the presence of auras. The phenomenological classifi- 
cation of epileptic attacks was further supplemented by 
the data from EEG and neuroimaging studies. The EEG 
features were divided into (i) non-localizing, when the 
EEG was either normal or showed diffuse background 
abnormalities or generalized spike and wave complexes 
(SWC) and (ii) focal, when the EEG showed focal inter- 
ictal epileptiform discharges (IBDs). The presence of 
focal lesions in neuroimaging studies was considered 
as evidence of PS. However, the lesions of questionable 
clinical significance, i.e. arachnoid cyst, venous an- 
gioma, and increased Tz-signal intensities in the white 
matter, etc., were not considered as evidence of PS. 
Although a history of remote CNS insults might sug- 
gest the presence of focal pathologies, its relationship 
with the seizure type or epileptic syndrome has not yet 
been clearly established, therefore it was not consid- 
ered for the classification of seizure types in this study. 
Clinical courses 
All patients kept seizure diaries during their clinic vis- 
its every 4 to 8 weeks. Their seizure recurrence and the 
timing of seizure occurrence in relation to sleep was 
recorded on the chart. 
The principles of AEDs treatment were initial maxi- 
mally tolerable monotherapy followed by either alter- 
native monotherapy or polytherapy. The choice of ini- 
tial AEDs was dependent upon the AEDs taken previ- 
ously as well as the type of seizures. Of 41 patients un- 
der AEDs therapy at their initial evaluation, 24 patients 
were taking single AED therapy: phenytoin (PHT) in 10 
patients, carbamazepine (CBZ) in six patients, pheno- 
barbital (PB) in four patients, sodium valproate (VPA) 
in four patients, and 17 patients were under polyther- 
apy. At the end of the 2-year follow-up, 33 patients were 
taking single AED treatment (CBZ, 18 patients; VPA, 
nine patients; PHT, five patients; PB, one patient) and 
eight patients were taking polytherapy. Of 22 patients 
new to AEDs, only one patient was taking two AEDs by 
the end of the 2-year follow-up. Eleven patients were 
under CBZ monotherapy, eight patients were taking 
VPA, and one patient was taking PHT. VPA monother- 
apy was the most common drug therapy in the group 
of S-GTCS (n = 12) as was CBZ monotherapy in the 
group of S-PE (n = 24). Blood levels of AEDs were 
measured selectively on the basis of clinical judgments. 
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The responses to the AEDs therapy were divided into 
three groups: (i) seizure-free, if the patients did not have 
any seizures for the second year of follow-up; (ii) im- 
proved, if the number of recurrent seizures during the 
second year of follow-up was reduced by 50% or more 
from the baseline frequency of seizures at their initial 
evaluation; (iii) not improved, if the number of seizures 
during the second year of follow-up was greater than 
50% of the baseline seizure frequencies. 
Statistics 
Statistical analyses were performed with the SAS pro- 
gram. Firstly, f-tests or chi-squared tests were used to 
compare the clinical characteristics of the S-PE and 
S-GTCS groups, the seizure-free and recurrent seizure 
groups, and the groups with sleep seizures alone and 
with WS. Secondly, the stepwise multiple logistic re- 
gression test was used to confirm the risk factors and to 
calculate the odd ratios with 95% confidence intervals 
of the selected variables. 
RESULTS 
Initially, ninety-five patients were found to have pure 
SE among 2000 patients who were newly registered 
to the YEC during the study period. Of those, 63 pa- 
tients satisfied the inclusion criteria and were anal- 
ysed. Twelve patients were identified as having be- 
nign rolandic epilepsy, one patient had juvenile my- 
oclonic epilepsy, 10 patients were lost before the 2 
years of follow-up, three patients were treated for a 
single episode of nocturnal seizure, and the timing 
of subsequent seizure recurrences in relation with the 
sleep-wake cycle could not be clearly identified in six 
patients. 
Classification of seizure types 
The details of seizure phenomenology clearly sug- 
gested PS in 26 patients and GMS without clear fo- 
cal features in the remaining 37 patients. EEGs dis- 
closed focal IEDs in 23 patients and generalized SWC 
in four patients. Neuroimaging studies were conducted 
in 61 of 63 patients, with CT scans in 22 patients and 
MRl in 39 patients. Focal lesions were found in 11 pa- 
tients (CT scan, three patients; MRI, eight patients). On 
the basis of combined seizure phenomenology, EEG 
and neuroimaging data, 21 of 37 patients with sleep 
GMS were assigned into the generalized tonic-clonic 
seizures during sleep (S-GTCS) group and the remain- 
ing 16 patients were moved into the group with partial 
epilepsies during sleep (S-PE), comprising a total of 42 
patients (Table 1). 
Baseline clinical characteristics 
The baseline clinical characteristics found in the two 
groups of SE are summarized in Table 2. The mean age 
of seizure onset, sex ratio, mean duration of illness prior 
to the initial evaluation and mean baseline seizure fre- 
quencies were not significantly different between the 
two groups. The history of significant remote CNS in- 
sults were found in 19 patients: three of 21 patients with 
S-GTCS and 16 of 42 patients with S-PE, which was 
not statistically significant (P > 0.05). The history of 
head trauma associated with a loss of consciousness or 
amnesia for longer than 30 minutes was found in only 
one patient with S-GTCS compared with 10 patients 
with S-PE, which was close to the level of statistical 
significance (P = 0.06). Family history of epilepsy 
in the first-degree relatives was found only in two pa- 
tients each in the S-GTCS and S-PF groups. Histories 
of febrile convulsions were present in 11 patients (four 
in S-GTCS and seven in S-PE). 
Focal TEDS in the EEG data were found in 23 of 42 
patients with S-PE and localized in the temporal lobe 
in 15 patients (left in six patients, right in eight, bitem- 
poral in one), the left temporo-parieto-occipital region 
in two patients, the frontal lobe in four patients (left in 
one patient and right in three patients), the bioccipital 
lobes in one patient, and the right hemisphere in one 
patient. Thus temporal lobe involvement was the most 
common (17 of 23 patients, 73.9%) with comparable 
lateralization of TEDS between the hemispheres (left, 
nine patients; right, 12 patients; bilateral, two patients). 
The neuroimaging studies showed significant focal 
lesions in 11 patients with S-PE, which included cav- 
ernous angioma (two patients), focal cortical dyspla- 
sia (one patient), focal calcified lesions (two patients), 
cerebromalacia (four patients), hippocampal atrophy 
(one patient), and cortical tubers with periventricular 
calcifications (one patient). The lateralization of lesions 
was also comparable between the hemispheres (left in 
four patients, right in six, bilateral in one). 
Responses to AEDs therapy 
(i) S-GTCS 
Of 21 patients with S-GTCS, 14 patients had had no 
seizures since their initial visit, one patient was seizure- 
free for the first year but had seizure recurrences during 
the second year, and three of six patients with recur- 
rent seizures during the first year achieved a seizure- 
free outcome at the second year of follow-up, so that 
seizure-free outcome was achieved in 17 patients. Of 
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Table 1: Classification of sleep epilepsies by phenomenology, EEG and neuroimaging data. 




N-L GEN FA 







(n = 37) 
PS 16 0 IO 7 1 14 4 0 26 
(n = 26) 
Total 36 4 23CV I9 3 31 W 21 42 
(II = 63) 
Number of natients with both focal IEDs and focal lesion in oarentheses: S-GMS. mand mal seizures without known focal features during 
sleep; S-PS: partial seizures with or without secondary gkneralized tonic-clonic seizures during sleep; N-L, non-lateralizing EE& 
GEN, generalized spike and slow wave complexes; FA, focal abnormalities: NEG. no significant focal lesions; S-GTCS, generalized 
tonic-clonic seizures during sleep; S-PE, partial epilepsies during sleep. 
Table 2: Clinical characteristics in patients with S-GTCS and S-PE. 
N-GTCS S-PE P-valuea 
Clinical features 
Aae of onset (years) 
SeX (male:fe&le) 
Duration of illness (years) 
Duration of F/U (months) 
Baseline seizure frequency 
(episodes/year) 
(n = 21) (n = 42) 
18.1 f 6.9 18.3 f 9.9 0.94 
l3:8 21:21 0.37 
9.3 f 5.6 7.3 f 6.8 0.56 
41.6 f 18.3 47.8 f 15.9 0.97 
6.4 i 8.3 8.1 zk 10.8 0.52 




History of febrile convulsion 











3 16 0.12 
I 10 0.06 
I 4 1.00 
1 2 1.00 
4 7 0.81 
2 2 0.47 
21(4)b I9 
0 23(L:9, R: 12, B:2) 
8 11 
0 3(L:I, R:l, B:l) 
I2 I9 
0 8(L:3, R:5, B:O) 
History of previous AEDs 
yes 
no 
a Calculated by t-test or chi-squared test. 




Table 3: Clinical variables associated with the seizure control outcomes of S-GTCS during the Z-year follow-up. 
Seizure-free Recurrent seizures 
Variables (n = 17) (n = 4) P-valuea 
Mean age of onset (years) 19.1 f 7.0 14.0 f 5.0 0.19 
Sex (male:femaJe) 
Mean seizure duration (years) 
Mean baseline seizure frequency 
(episode/year) 
History of CNS insults (n = 1) 
History of head trauma (n = 1) 
IO:7 3:l 0.56 
6.8 f 5.8 lS.Of4.1 0.02 
4.8 zk 6.5 13.3 -f 12.4 0.06 
1(5.9%) 0 
0 1125.0%) 
History of febrile convulsion (n = 4) 
a Calculated by f-test or chi-squared test. 
3( 17.6%) I i2S.O%j 
Sleep epilepsies 
four patients with recurrent seizures throughout the 2 
years of follow-up, three patients improved and one did 
not. Therefore, the group of S-GTCS showed an excel- 
lent response to AEDs therapy with a terminal l-year 
seizure remission rate of 8 1% at the end of the 2-year 
follow-up. 
Of the many clinical variables analysed (Table 3), 
only the longer duration of illness was significantly re- 
lated to a poor seizure control outcome (P = 0.02). 
The higher baseline seizure frequency tended to be as- 
sociated with poor seizure control, but it did not reach 
a significant level (P = 0.06). 
(ii) S-PE 
Of 42 patients with S-PE, 14 patients were seizure- 
free following their initial clinic visit and one patient 
achieved a seizure-free outcome during the second year 
of follow-up, 23 patients improved and four did not 
(Table 4). Of 29 patients who had been exposed to 
AEDs therapy at their initial clinic visit, 10 patients 
showed a serum level of AEDs within the therapeutic 
level, and only one of them achieved a seizure-free out- 
come. Of 19 patients with subtherapeutic serum levels 
of AEDs at their initial evaluation, eight patients be- 
came seizure-free, 10 patients improved, and one pa- 
tient did not. Six of 13 patients new to AEDs therapy 
became seizure-free, six patients improved and one pa- 
tient did not. Therefore, of 32 patients who had been 
previously either inadequately treated or untreated, 14 
patients became seizure-free (43.8%), 16 patients im- 
proved (50%), and two patients did not improve (6.3%). 
These features were in clear contrast to the outcome of 
the patients with S-GTCS but were not different from 
the reported outcomes of previously untreated or un- 
dertreated partial epilepsy’3. 
For the subgroup analysis of S-PE, we compared the 
outcomes of 16 patients, who presented with S-GMS 
but were reclassified into S-PE due to either focal IEDs 
in EEG or focal lesions found in the neuroimaging stud- 
ies, with the outcomes of 26 patients who were classi- 
fied into S-PE due to the unequivocal evidence of partial 
seizures in phenomenology. Seizure-free outcome was 
achieved in four of the 16 patients presenting with S- 
GMS and in 11 of the 26 patients presenting initially 
with sleep PS, which was not significantly different 
(P > 0.05). Therefore, the analysis of clinical vari- 
ables in patients with S-PE did not reveal any signifi- 
cant factors related to the outcome of seizure control. 
Development of wake seizure 
Throughout the 2-year follow-up period, 34 patients 
developed recurrent seizures (three patients became 
seizure-free during the second year) and 12 of them 
developed WS. There were significant differences in 
the incidence of WS between the two groups of pa- 
tients. S-GTCS and S-PE. 
(i, S-GTCS 
Of 21 patients with S-GTCS, only one of seven patients 
who had experienced recurrent seizures (three patients 
became seizure-free in the second year) during the 2 
years of follow-up developed new WS. This patient had 
a history of 13 years of seizure duration with an average 
baseline seizure frequency of two episodes per month. 
He was taking phenytoin (PHT) and the serum level 
was found at the initial evaluation to be 27.75pg/ml. 
A WS occurred at the 4th month of follow-up. The phe- 
nomenology of his WS consisted of-initial vocalization 
with head turning to the left side followed by GTCS. 
He also reported an aura consisting of fear just before 
his loss of consciousness, which was consistent with a 
partial-onset secondary GTCS. 
(io S-PE 
Table 5 summarized the clinical variables associated 
with the development of new WS in patients with S-PE. 
Of 27 patients who had experienced recurrent seizures 
during the 2 years of follow-up, 11 patients developed 
WS, and 16 patients continued to have SE. The mean 
age of onset and sex ratio were not significantly differ- 
ent in the groups of patients with continuing SE and 
newly developed WS. However, the duration of illness 
was longer (P = 0.03) and the baseline seizure fre- 
quency was higher (P = 0.02) in patients with WS 
than in patients with recurrent sleep seizures only. The 
statistical significance of those two variables was fur- 
ther confirmed by the stepwise multiple logistic re- 
gression model. The odd ratios for the duration of 
illness (years) and for the baseline seizure frequency 
(episodes/year) were 1.3 with 95% confidence inter- 
vals of 1.1 to 1.6 and 1.1 to 1.5, respectively. In the 
subgroup analysis, presence of focal TEDS and the his- 
tory of remote CNS insults did not show any significant 
differences from the overall outcomes of S-PE. The in- 
cidence of WS was higher in patients with a history 
of head trauma, but it did not reach a significant level 
(P = 0.06). 
Of 42 patients with S-PE, 40 patients were followed 
for longer than 2 years (range : 25 to 82 months), and 
11 patients (nine of 27 patients with recurrent seizures 
and two of 13 patients with a seizure-free outcome) 
newly developed WS during the extended follow-up 
period. Therefore, 22 of 42 patients with S-PE (52.4%) 
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Table 4: Clinical variables associated with the seizure control outcomes of S-PE during the P-year follow-up. 
Seizure-free Recurrent seizures 
Variables 
Mean age of onset (years) 
Sex (male:femaie) 
Mean seizure duration (years) 
Mean baseline seizure frequency 
(episodes/year) 
Focal EDs (n = 23) 
Focal lesion (n = 11) 
History of CNS insults (n = 16) 
Histon, of head trauma (n = 10) 
(n = 15) 
18.0 f 9.6 
(n = 27) 
18.6 f 10.3 
P-valuea 
0.84 
6:9 15:12 0.34 
5.4 f 5.3 8.4 f 7.4 0.17 
4.6 i 4.2 10.1 f 12.8 0.15 
8(53.3%) 15(55.6%) 0.90 
4(26.7%) 7(25.9%) 0.96 
5133.3%) 11140.7%) 0.50 
2( 13.3%) 8(29.6%) 0.24 
Histoj of febrile convulsion (n.= 7) 
B Calculated by I-test or chi-squared test. 
3(20.0%) 4( 14.8%) 0.67 
developed diurnal attacks during the entire follow-up 
period of 47.8 f 15.9 months. The mean duration of 
pure SE in these 22 patients who developed WS was 
131.1 f 87.2 months. 
DISCUSSION 
SE is a heterogeneous condition consisting of different 
seizure types, various etiologies of seizures, different 
ages of onset, and different clinical courses, which in- 
terferes with the identification of SE as a distinct clin- 
ical entity. The awareness of subsequent WS in some 
patients who were initially recognized as pure SE posed 
a fundamental doubt about the existence of pure SE. 
In this study, we tried to investigate the clinical 
courses of SE in relation to their seizure types, which 
has not previously been systematically conducted. The 
classification of seizure type was made by a thor- 
ough history-taking, supplemented by EEG and neuro- 
imaging data, similar to the usual practice. Two-thirds 
of the patients were successfully classified into S-PE, 
which was similar to the overall distribution of par- 
tial epilepsies in the general population. For patients 
presenting with generalized convulsions, lacking de- 
tailed descriptions about the initial part of attacks and 
negative results of EEG and neuroimaging studies, the 
exact diagnosis of seizure types may be problematic. 
On these occasions a prolonged CCTV-EEG recording 
may be beneficial, however, its use should be reserved 
only for selected cases on the basis of careful clinical 
judgment. Therefore, the inclusion of CCTV-EEG data 
may not help much for predicting the clinical course of 
SE at the level of clinic practice. 
Sleep GTCS 
The clinical courses of 2 1 patients assigned to S-GTCS 
were characterized by their excellent response to AEDs 
therapy (seizure-free in 8 1%) comparable to that of id- 
iopathic generalized epilepsies14 and a very rare occur- 
rence of diurnal attacks (4.8%). 
It is likely that a large number of these patients may 
have, in fact, idiopathic GTCS. However, typical gen- 
eralized SWCs in EEG were seen in only four patients 
and the descriptions of their seizure onset were often 
unclear. In addition, the seizure phenomenology of 
the patient who developed WS was consistent with a 
partial-onset secondary GTCS. Therefore, it is quite 
possible that some of these patients might have sec- 
ondary GTCS instead of idiopathic GTCS. However, 
all these patients had GTCS only without any known 
focal features in both clinical and laboratory investi- 
gations, which was clearly different from the group of 
S-PE. Even in patients with PE, as recently reported 
by Mattson et al 15, the prognosis for secondary GTCS 
alone was far better than for CPS alone or mixed 
seizures. Thus, from a clinical aspect, it seems reason- 
able to treat them all as one group, S-GTCS. 
Idiopathic GTCS alone is a clinical entity found 
in approximately 25% of all idiopathic generalized 
epilepsies and usually characterized by its benign 
course with infrequent attacks16. At present, GTCS on 
awakening is the only epileptic syndrome applicable 
to this group of patients but this syndrome has recently 
been disputed because a large proportion of patients 
with GTCS alone do not fit its criteria. Reutens and 
Berkovic” investigated 101 patients with idiopathic 
generalized epilepsies and found 17 patients with 
GTCS alone. Of those, 10 patients did fit the criteria of 
GTCS on awakening. Three of the remaining seven pa- 
tients had true sleep GTCS which was characterized by 
a very low frequency of seizures, usually less than one 
episode per month or less than 10 seizures in total, and 
an excellent response to AEDs therapy. Sleep GTCS 
was also found in five of 84 patients with eitberjuvenile 
myoclonic epilepsy or absence epilepsy, which were 
excluded from this study. The relationship between 
the occurrence of seizures and circadian rhythm seems 
to be a rule for idiopathic generalized epilepsies17 
and their mechanisms share common neuroanatomical 
structures (brainstem and thalamus), thus it is quite 
likely that a proportion of idiopathic GTCS alone may 
have an intimate relationship with sleep and behave 
Sleep epilepsies 375 





Mean aae of onset (vears) 
(n = 16) 
21.3f11.6 
(n = 11) 
14.6 3~ 6.6 
P-valuea 
NS 
Sex (mtYle:female) ‘- 9:7 65 NS 
Mean seizure duration (years) 6.0 f 5.3 12.0 f 8.8 0.03 
Mean baseline seizure frequency (episodes/year) 4.7 f 5.0 17.9 f 16.6 0.02 
Focal IEDs (n = 23) 8(50.0%) 7(63.6%) 0.48 
Focal lesion (n = 11) 5(31.2%) 2(18.2%) 0.45 
History of Cns insults (n = 16) 6(37.5%) 5(45.5%) 0.68 
History of head trauma (n = IO) 3(18.8%) 5(45.5%) 0.14 
History of febrile convulsion (n = 7) 3(18.8%) 
a Calculated by f-test or chi-squared test. IED, interictal epileptiform discharge. 
1(9.0%) 0.49 
like pure SE. The mean duration of pure S-GTCS in 
our four patients with generalized SWC was 8 years 
(range : 3 to 13 years) with infrequent seizures (range : 
0.3 to 3 episodes/year) and all of them entered into a 
prolonged remission after appropriate AEDs therapy. 
These patients were quite similar to the three patients 
described by Reutens and Berkovic” and they might 
be considered as idiopathic S-GTCS with reference to 
the GTCS on awakening characteristic. 
Despite the uncertainties about the true types of 
epilepsy in patients with S-GTCS, we were able to 
conclude that the patients presenting with recurrent 
sleep GMS without any focal features in seizure phe- 
nomenology, EEG and neuroimaging studies carry an 
excellent prognosis and the chance of developing new 
WS is very low. 
Sleep partial epilepsy 
The clinical courses of the patients with S-PE were 
quite different from the group of S-GTC, as was char- 
acterized by their poor responses to AEDs therapy and 
much higher incidence of WS. Seizure-free outcome 
was achieved in 15 of42 patients (35.7%) or in six of 13 
patients (46.2%) new to AEDs, which was essentially 
similar to the general seizure control outcome in partial 
epilepsy . I3 However, the incidence of focal lesions in 
MRI (eight of 27 patients: 29.6%) was relatively lower 
in this group of patients than in the general popula- 
tion of partial epilepsy patients attending the epilepsy 
clinic. The incidence of focal lesions in MRI in patients 
with partial epilepsy was 51.4% in the study of Resta 
et a/l7 and was 5 1.6% in our epilepsy clinic” with 
hippocampal sclerosis being the most frequent (59.4% 
of all lesions). In this study the typical MRI features 
of hippocampal sclerosis was found in only one pa- 
tient despite 15 patients showing localized focal IEDs 
in the temporal lobe in EEG. The reason for the lower 
incidence of hippocampal sclerosis in our patients with 
S-PE is unclear, however, the lower incidence of focal 
lesions and the diverse nature and location of patholo- 
gies found in this group of patients suggest that focal 
lesions are not specifically related to SE, which is in 
agreement with the data of Young ei al’. The high in- 
cidence of the history of significant head trauma in this 
population (23.8%) was an interesting phenomenon as 
previously suggested by Young et al’. We speculate 
that shearing injury to the brainstem, a structure re- 
sponsible for the modulation of sleep-wake cycles, by 
a significant closed head injury may be related in some 
way with the subsequent development of SE. The re- 
lationship between post-traumatic epilepsy and sleep 
clearly needs further investigation. 
The high incidence of WS in this group of patients, 
especially in patients with prolonged duration of pure 
S-PE, was an unexpected finding. Of 27 patients with 
recurrent sleep attacks, 11 developed new WS during 
the 2 years of follow-up and we were able to find 11 ad- 
ditional patients who developed new WS during their 
extended follow-up of 47.8 f 15.9 months, which sug- 
gested that the development of WS was quite high in pa- 
tients with S-PE unless their seizures were completely 
controlled throughout. 
Previous investigators suggested that the risk of 
WS was higher in patients with a shorter duration of 
illness’*4,5. In contrast, the incidence of WS was higher 
in patients with longer duration and higher baseline 
seizure frequencies in this study. The average duration 
of illness from the onset of SE to the development of 
WS in these patients was 131.1 f 87.2 months and the 
baseline seizure frequency was 17.9 f 16.6 episodes 
per year. Although no specific duration of illness as- 
sociated with the development of WS could be found 
in this study, our data indicated that a longer duration 
of illness increases the risk of developing WS by the 
rate of 1.3 per year (95% CI: 1.1 to 1.6), which argues 
against the previous concepts on the importance of an 
initial several years of follow-up to be able to diagnose 
pure SE. 
Reasons for these differences from previous studies 
are unclear but may be related to two possibilities. First, 
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previous investigators had included both partial and 
generalized SE, which might have diluted the higher 
incidence of diurnal attacks in patients with S-PE. Sec- 
ond, a majority of the patients recruited to the previous 
studies had a shorter duration of SE, but a larger propor- 
tion of S-PE in this study (25 of 42 patients) had longer 
than 3 years of seizure duration at the time of initial 
evaluation, which was probably related to the differ- 
ent social environment. There is a strong social stigma 
against epilepsy in Korean society, probably related to 
a long traditional Confucian concept stressing a strict 
moral code in social activities, which might interfere 
with patients seeking medical care or exposing their ill- 
ness, especially when their seizures occur exclusively 
during sleep. 
Recently, Shinnar er al*’ investigated the risk of sub- 
sequent recurrent seizures in patients registered after 
their tirst unprovoked seizure. Interestingly, the chance 
of recurrent seizures was higher in patients who had 
their first seizure during sleep, and their subsequent 
seizures were more likely to occur during sleep. If the 
patient had the first two seizures during sleep, the prob- 
ability of having their third seizure during sleep was ap- 
proximately 90%. These findings clearly suggest that 
there is a group of patients having closer interactions 
between sleep and epilepsy, but with variable degrees 
of interaction in different individuals. 
The group of patients with shorter duration of pure 
SE may include many patients with looser interactions 
between sleep and seizure occurrence, who will de- 
velop WS early. In contrast, the group of patients with 
a longer duration of pure SE may represent the presence 
of stronger interactions. However, unless the degree of 
interactions was total, the chance of developing WS 
may increase as they continue to have more seizure 
recurrences over a prolonged period, thus the chance 
of developing WS may be higher in patients with a 
longer duration of pure S-PE. This hypothesis that, the 
more seizures the patient has, the higher the risk of 
developing WS, is also in agreement with the strong 
effect of higher seizure frequencies on the risk of de- 
veloping new WS. This is again consistent with the 
fact that infrequent seizure recurrence was one of the 
characteristics of pure SE both in humans’*5 and kin- 
dled animals*l . It seems apparent that the less frequent 
seizure recurrences should prolong the duration of pure 
SE, however, they may develop new WS eventually as 
they continue to have recurrent seizures over a longer 
period, 
We conclude that a thorough evaluation of the pa- 
tients with S-PE is crucial for predicting their future 
clinical course. Patients with S-GTCS without any fo- 
cal features in seizure phenomenology, EEG and neu- 
roimaging studies easily enter into a prolonged seizure 
remission and the risk of developing WS is quite low. 
With respect to the GTCS on awakening criterion, some 
S. A. Park et 8/ 
of these patients (especially those having infrequent 
attacks) may have idiopathic S-GTCS. On the other 
hand, patients with S-PE were associated with unfa- 
vorable seizure control outcomes and a high incidence 
of developing WS. In this group of patients the risk 
of developing WS may increase if patients continue 
to have recurrent seizures over a longer period, which 
suggests that the interactions between sleep and seizure 
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